Medical termination of pregnancy

New England Journal of Medicine

Volumn 342, Issue 13, 2000, Pages 946-956

  Christin Maitre, Sophie ^a   Bouchard, Philippe ^a   Spitz, Irving M ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; CARBOPROST; EPOSTANE; GEMEPROST; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN DERIVATIVE; SULPROSTONE; TAMOXIFEN;

ABORTION; DNA SYNTHESIS; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; NAUSEA; PAIN; PREGNANCY TERMINATION; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS; TROPHOBLAST; UTERUS CONTRACTILITY; VAGINA BLEEDING; VOMITING;

ABORTIFACIENT AGENTS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; BIOLOGY; DRUGS; ENDOCRINE SYSTEM; FAMILY PLANNING; FERTILITY AGENTS; FERTILITY CONTROL, POSTCONCEPTION; LITERATURE REVIEW; METHOTREXATE; MISOPROSTOL; PHYSIOLOGY; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; REPRODUCTIVE CONTROL AGENTS; TAMOXIFEN; TREATMENT;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; ALPROSTADIL; DRUG COMBINATIONS; FEMALE; HUMANS; METHOTREXATE; MIFEPRISTONE; PREGNANCY; PROGESTERONE; PROSTAGLANDINS; UTERINE CONTRACTION;

EID: 0034732147     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200003303421307     Document Type: Review

References (100)

1. Abortion in fact: levels, trends and patterns. In: Sharing responsibility: women, society & abortion worldwide. New York: Alan Guttmacher Institute, 1999:25-31.
2. Henshaw SK. Abortion incidence and services in the United States, 1995-1996. Fam Plann Perspect 1998;30:263-70, 287.
3. Rosenfield A. Mifepristone (RU 486) in the United States: what does the future hold? N Engl J Med 1993;328:1560-1.
4. Task Force on Postovulatory Methods of Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Lancet 1999;353:697-702.
5. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. Hum Reprod 1995;10:308-14.
6. Spitz IM, Bardin CW. Mifepristone (RU 486) - a modulator of progestin and glucocorticoid action. N Engl J Med 1993;329:404-12.
7. Giudice LC. Implantation and endometrial function. In: Fauser BCJM, ed. Molecular biology in reproductive medicine. New York: Parthenon Publishing Group, 1999:333-52.
8. Chwalisz K, Garfield RE. Regulation of the uterus and cervix during pregnancy and labor: role of progesterone and nitric oxide. Ann N Y Acad Sci 1997;828:238-53.
9. Izumi H, Garfield RE, Morishita F, Shirakawa K. Some mechanical properties of skinned fibres of pregnant human myometrium. Eur J Obstet Gynecol Reprod Biol 1994;56:55-62.
10. Grazzini E, Guillon G, Mouillac B, Zingg HH. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998;392: 509-12.
11. Creange JE, Anzalone AJ, Potts GO, Schane HP. Win 32,729, a new, potent interceptive agent in rats and rhesus monkeys. Contraception 1981; 24:289-99.
12. Philibert D, Draedt R, Teutsch G. RU 38486: a potent antiglucocorticoid in vivo. In: Yoshida H, Hagihara Y, Ebashi S, eds. CNS pharmacology, neuropeptides. Oxford, England: Pergamon Press, 1982.
13. Baulieu E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 1989;245:1351-7.
14. Spitz IM, Bardin CW. Clinical pharmacology of RU 486 - an antiprogestin and antiglucocorticoid. Contraception 1993;48:403-44.
15. Johannisson E, Oberholzer M, Swahn ML, Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception 1989;39:103-17.
16. Garfield RE, Blennerhassett MG, Miller SM. Control of myometrial contractility: role and regulation of gap junctions. Oxf Rev Reprod Biol 1988;10:436-90.
17. Bleyer WA. The clinical pharmacology of methotrexate: new applications of an old drug. Cancer 1978;41:36-51.
18. Tanaka T, Hayashi H, Kutsuzawa T, Fujimoto S, Ichinoe K. Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril 1982;37:851-2.
19. Fernandez H, Yves Vincent SC, Pauthier S, Audibert F, Frydman R. Randomized trial of conservative laparoscopic treatment and methotrexate administration in ectopic pregnancy and subsequent fertility. Hum Reprod 1998;13:3239-43.
20. Castadot RG. Pregnancy termination: techniques, risks, and complications and their management. Fertil Steril 1986;45:5-17.
21. 21. Rodger MW, Logan AF, Baird DT. Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost). Contraception 1989;39:497-502.
22. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-7.
23. Birgerson L, Olund A, Odlind V, Somell C. Termination of early human pregnancy with epostane. Contraception 1987;35:111-20.
24. Crooij MJ, de Nooyer CCA, Rao BR, Berends GT, Gooren LJG, Janssens J. Termination of early pregnancy by the 3β-hydroxysteroid dehydrogenase inhibitor epostane. N Engl J Med 1988;319:813-7.
25. Webster MA, Phipps SL, Gillmer MD. Interruption of first trimester human pregnancy following epostane therapy: effect of prostaglandin E2 pessaries. Br J Obstet Gynaecol 1985;92:963-8.
26. Karim SM, Filshie GM. Therapeutic abortion using prostaglandin F2alpha. Lancet 1970;1:157-9.
27. Ulmann A, Silvestre L, Chemama L, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: study in 16,369 women. Acta Obstet Gynecol Scand 1992;71:278-83.
28. Coelho HL, Teixeira AC, Santos AP, et al. Misoprostol and illegal abortion in Fortaleza, Brazil. Lancet 1993;341:1261-3. [Erratum, Lancet 1993;341:1486.]
29. Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993;341:1258-61.
30. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991;338:1233-6.
31. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
32. Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol 1997;89:768-72.
33. Bugalho A, Faundes A, Jamisse L, Usfa M, Maria E, Bique C. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception 1996;53:243-6.
34. Creinin MD, Vittinghoff E. Methotrexate and misoprostol vs misoprostol alone for early abortion: a randomized controlled trial. JAMA 1994;272:1190-5.
35. Koopersmith TB, Mishell DR Jr. The use of misoprostol for termination of early pregnancy. Contraception 1996;53:238-42.
36. Carbonell JL, Varela L, Velazco A, Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997;55:165-8.
37. Norman JE, Thong KJ, Rodger MW, Baird DT. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison be tween gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost. Br J Obstet Gynaecol 1992;99:601-6.
38. Carbonell JL, Varela L, Velazco A, Fernandez C, Sanchez C. The use of misoprostol for abortion at < or = 9 weeks' gestation. Eur J Contracept Reprod Health Care 1997;2:181-5.
39. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995;333:537-40.
40. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996;53:321-7.
41. Schaff EA, Wortman M, Eisinger SH, Franks P. Methotrexate and misoprostol when surgical abortion fails. Obstet Gynecol 1996;87:450-2.
42. Wiebe ER. Abortion induced with methotrexate and misoprostol. CMAJ 1996;154:165-70.
43. Creinin MD. Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol. Contraception 1997;56:367-71.
44. Wiebe ER. Abortion induced with methotrexate and misoprostol: a comparison of various protocols. Contraception 1997;55:159-63.
45. Creinin MD, Carbonell JL, Schwartz JL, Varela L, Tanda R. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception 1999; 59:11-6.
46. Wiebe ER. Comparing abortion induced with methotrexate and mi soprostol to methotrexate alone. Contraception 1999;59:7-10.
47. Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997;90:611-6.
48. Carbonell JL, Varela L, Velazco A, Cabezas E, Fernandez C, Sanchez C. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1998;57:83-8.
49. Carbonell Esteve JL, Varela L, Velazco A, Tanda R, Sanchez C. 25 mg Or 50 mg of oral methotrexate followed by vaginal misoprostol 7 days after for early abortion: a randomized trial. Gynecol Obstet Invest 1999;47:182-7.
50. Mishell DR Jr, Jain JK, Byrne JD, Lacarra MD. A medical method of early pregnancy termination using tamoxifen and misoprostol. Contraception 1998;58:1-6.
51. Danielsson K, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93:275-80.
52. Cameron IT, Baird DT. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486. Br J Obstet Gynaecol 1988;95:271-6.
53. Fonseca W, Alencar AJ, Mota FS, Coelho HL. Misoprostol and congenital malformations. Lancet 1991;338:56.
54. Gonzalez CH, Vargas FR, Perez AB, et al. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993; 47:59-64.
55. Gonzalez CH, Marques-Dias MJ, Kim CA, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998;351:1624-7.
56. Pastuszak AL, Schüler L, Speck-Martins CE, et al. Use of misoprostol during pregnancy and Möbius' syndrome in infants. N Engl J Med 1998; 338:1881-5.
57. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993;307:532-7.
58. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13:2962-5.
59. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339-48. [Erratum, Contraception 1994; 49:99.]
60. Schaff EA, Eisinger SH, Franks P, Kim SS. Methotrexate and misoprostol for early abortion. Fam Med 1996;28:198-203.
61. Haiprin KM, Fukui K, Okawara A. Blood levels of methotrexate and the treatment of psoriasis. Arch Dermatol 1971;103:243-9.
62. Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology 1994; 49:79-81.
63. Herrmann W, Wyss R, Riondel A, et al. Effet d'un steroide antiprogestérone chez la femme: interruption du cycle menstruel et de la grossesse au début. C R Acad Sci III 1982;294:933-8.
64. Couzinet B, Le Strat N, Ulmann A, Baulieu EE, Schaison G. Termination of early pregnancy by the progesterone antagonist RU 486 (mifepristone). N Engl J Med 1986;315:1565-70.
65. Swahn ML, Kovacs L, Cekan SZ, Aedo AR, Westlund P. Termination of early pregnancy with ZK 98,734: pharmacokinetic behaviour and clinical effect. Hum Reprod 1994;9:57-63.
66. Bygdeman M, Swahn ML. Progesterone receptor blockage: effect on uterine contractility and early pregnancy. Contraception 1985;32:45-51.
67. el-Refaey H, Templeton A. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure. Br J Obstet Gynaecol 1994;101:792-6.
68. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332:983-7.
69. Broome M. Using mifepristone in a family planning clinic. Br J Fam Plann 1994;20:11-2.
70. World Health Organization. Pregnancy termination with mifepristone and gemeprost: a multicenter comparison between repeated doses and a single dose of mifepristone. Fertil Steril 1991;56:32-40.
71. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44:353-60.
72. Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 1992;99:1004-7
73. Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu E-E, Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue: a large-scale French experience. N Engl J Med 1990;322:645-8.
74. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod 1993;8:1502-5.
75. Thonneau P, Poirel H, Fougeyrollas B, et al. A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600 mg) and vacuum aspiration. Hum Reprod 1995;10:1512-5.
76. Wu S, Gao J, Wu Y, et al. Clinical trial on termination of early pregnancy with RU486 in combination with prostaglandin. Contraception 1992;46:203-10.
77. Peyron R, Aubény E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-13.
78. Sang GW, Weng LJ, Shao QX, et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05 - a multicentre randomized clinical trial in China. Contraception 1994;50:501-10.
79. Thonneau P, Fougeyrollas B, Spira A. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center. Fertil Steril 1994;61:627-31.
80. Baird DT, Sukcharoen N, Thong KJ. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Hum Reprod 1995;10:1521-7.
81. Penney G, McKessock L, Rispin R, El-Refaey H, Templeton A. An effective low-cost regimen for early medical abortion. Br J Fam Plann 1995;21:5-6.
82. Aubeny E, Peyron R, Turpin CL, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995;40:Suppl 2:85-91. [Erratum, Int J Fertil Menopausal Stud 1996;41:56.]
83. Urquhart DR, Templeton AA, Shinewi F, et al. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation: UK Multicenter Study - final results. Contraception 1997;55:1-5.
84. Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997; 176:431-7.
85. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1-6.
86. Prasad RN, Choolani M. Termination of early human pregnancy with either 50 mg or 200 mg single oral dose of mifepristone (RU486) in combination with either 0.5 mg or 1.0 mg vaginal gemeprost. Aust N Z J Obstet Gynaecol 1996;36:20-3.
87. Chan YF, Ho PC, Ma HK. Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost. Contraception 1993;47:85-95.
88. Harper C, Winikoff B, Ellertson C, Coyaji K. Blood loss with mifepristone-misoprostol abortion: measures from a trial in China, Cuba and India. Int J Gynaecol Obstet 1998;63:39-49.
89. Blinder V, Elul B, Winikoff B. Mifepristone-misoprostol medical abortion: who will use it and why? Am J Obstet Gynecol 1998;179:1376.
90. Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception 1998;58:99-103.
91. Tang OS, Gao PP, Cheng L, Lee SW, Ho PC. A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol. Hum Reprod 1999;14:722-5.
92. Jost A. Nouvelles données sur le besoin hormonal de la lapine gesante: grossesses partielles et anomalies foetales après traitement par un antagoniste hormonal à dose sub-abortive. C R Acad Sci III 1986;303:281-4.
93. Sitruk-Ware R, Davey A, Sakiz E. Fetal malformation and failed medical termination of pregnancy. Lancet 1998;352:323.
94. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol: results of a large multicenter trial in the United States. Arch Fam Med 1998;7:360-6.
95. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994;9:2167-72.
96. Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996;54:15-8.
97. Cameron ST, Glasier AF, Login J, Benton L, Baird DT. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. Br J Obstet Gynaecol 1996;103:1222-9.
98. Elul B, Ellertson C, Winikoff B, Coyaji K. Side effects of mifepristone-misoprostol abortion versus surgical abortion: data from a trial in China, Cuba, and India. Contraception 1999;59:107-14.
99. Jensen JT, Astley SJ, Morgan E, Nichols MD. Outcomes of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Contraception 1999;59:153-9.
100. Cabezas E. Medical versus surgical abortion. Int J Gynaecol Obstet 1998;63:Suppl 1:S141-S146.